These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 29306230

  • 1. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
    Akın Ş, Yazgan Aksoy D, Akın S, Kılıç M, Yetişir F, Bayraktar M.
    Turk J Med Sci; 2017 Dec 19; 47(6):1723-1727. PubMed ID: 29306230
    [Abstract] [Full Text] [Related]

  • 2. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J, Li J, Chen X, Lin X, Du J, Zhao G, Chen Z, Wu Z.
    Bull Cancer; 2017 Jun 19; 104(6):516-523. PubMed ID: 28476312
    [Abstract] [Full Text] [Related]

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW, Qu Z, Qin AC, Pan H, Ye J, Jiang Y.
    Eur J Surg Oncol; 2020 Oct 19; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [Abstract] [Full Text] [Related]

  • 4. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q, Wang Z, Meng X, Duh QY, Chen G.
    Asian J Surg; 2019 Apr 19; 42(4):571-576. PubMed ID: 30348606
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY, Qiu SL, Peng ZH, Wang M.
    J Endocrinol Invest; 2018 Apr 19; 41(4):403-409. PubMed ID: 28884301
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW, Ye J, Wu WX, Qu Z, Qin AC, Jiang Y.
    J Endocrinol Invest; 2020 Dec 19; 43(12):1807-1817. PubMed ID: 32557354
    [Abstract] [Full Text] [Related]

  • 10. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
    Liu LS, Liang J, Li JH, Liu X, Jiang L, Long JX, Jiang YM, Wei ZX.
    Eur Arch Otorhinolaryngol; 2017 Mar 19; 274(3):1327-1338. PubMed ID: 27645473
    [Abstract] [Full Text] [Related]

  • 11. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
    Kim SK, Park I, Woo JW, Lee JH, Choe JH, Kim JH, Kim JS.
    Ann Surg Oncol; 2016 Sep 19; 23(9):2866-73. PubMed ID: 27075321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
    Qiu P, Guo Q, Pan K, Lin J.
    BMC Cancer; 2024 Feb 20; 24(1):235. PubMed ID: 38378515
    [Abstract] [Full Text] [Related]

  • 19. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
    Li XJ, Yang L, Ma BL.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan 20; 31(1):52-57. PubMed ID: 29774686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.